Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
[Vitamin D and multiple sclerosis : The role for risk of disease and treatment.]
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Depression screening in Black Americans with multiple sclerosis.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Saffold Virus Type 3 (SAFV-3) Persists in HeLa Cells.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US.
Determining the Presence of Reliable Change over Time in Multiple Sclerosis: Evidence from the PASAT, Adjusting-PSAT, and Stroop Test.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Resilience and vulnerability in individuals with chronic pain and physical disability.
Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Benefits of whole-body vibration with an oscillating platform for people with multiple sclerosis: a systematic review.
Anorectal dysfunction in multiple sclerosis: a systematic review.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study.
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial.
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Clinical experience of natalizumab in Crohn's disease patients in a restricted distribution program.
Multiple sclerosis care in Latin America.
Cognitive impairment in relapsing remitting and secondary progressive multiple sclerosis patients: efficacy of a computerized cognitive screening battery.
The multiple sclerosis depression rating scale.

Pages